Rapid Antiretroviral Therapy Among Individuals With Acute and Early HIV.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32777035.
- Also identified by DOI 10.1093/cid/ciaa1174 and PMC identifier 8246801.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HIV transmission is increased during acute and early HIV (AEH). Rapid antiretroviral therapy may shorten the duration of infectivity. We show rapid antiretroviral therapy in AEH is acceptable and effective, with 69.0% of participants starting ART within 7 days of HIV diagnosis disclosure, and 88.1% achieving suppression by 48 weeks.
Medical subject headings
- HIV Infections